Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Integra Lifesciences Holdings (IART) Total Non-Current Liabilities (2016 - 2025)

Integra Lifesciences Holdings' Total Non-Current Liabilities history spans 17 years, with the latest figure at $2.4 billion for Q4 2025.

  • For Q4 2025, Total Non-Current Liabilities changed 0.36% year-over-year to $2.4 billion; the TTM value through Dec 2025 reached $2.4 billion, changed 0.36%, while the annual FY2025 figure was $2.4 billion, 0.36% changed from the prior year.
  • Total Non-Current Liabilities for Q4 2025 was $2.4 billion at Integra Lifesciences Holdings, down from $2.4 billion in the prior quarter.
  • Across five years, Total Non-Current Liabilities topped out at $2.4 billion in Q2 2024 and bottomed at -$1.8 billion in Q3 2021.
  • The 5-year median for Total Non-Current Liabilities is $2.0 billion (2022), against an average of $1.6 billion.
  • The largest annual shift saw Total Non-Current Liabilities plummeted 194.64% in 2021 before it surged 216.55% in 2022.
  • A 5-year view of Total Non-Current Liabilities shows it stood at $2.0 billion in 2021, then increased by 4.2% to $2.1 billion in 2022, then rose by 6.49% to $2.2 billion in 2023, then rose by 6.92% to $2.3 billion in 2024, then grew by 0.36% to $2.4 billion in 2025.
  • Per Business Quant, the three most recent readings for IART's Total Non-Current Liabilities are $2.4 billion (Q4 2025), $2.4 billion (Q3 2025), and $2.4 billion (Q2 2025).